New Covid-19 vaccine demonstrates ‘89% efficacy’, with UK having 60m orders

Published on January 28, 2021 - Duration: 00:33s

New Covid-19 vaccine demonstrates ‘89% efficacy’, with UK having 60m orders

An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax.

The UK hassecured access to 60 million doses of the vaccine, called NVX-CoV2373.


You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2
Tech giant Apple has recorded the biggest drop in iPhone sales since the early months of the COVID pandemic.
Credit: Sky News - Published 2 days ago

In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
Credit: DNA - Published 4 days ago

Two companies are being sued by the British government for over £145m after they allegedly supplied defective COVID-19 tests.
Credit: Sky News - Published 4 days ago

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known..
Credit: Sky News - Published 5 days ago


Related videos from verified sources

Truss criticises Macron's AstraZeneca efficacy comments 00:35
Video credit: PA - Press Association STUDIO - Published on January 31, 2021 

'BJP hellbent on creating hatred for Muslims': Asaduddin Owaisi | The Interview 19:04
Video credit: HT Digital Content - Published on January 31, 2021 

New Campaign Launches To Increase Confidence In COVID-19 Vaccine Among Maryland's Black, Latinx Communities 02:36
Video credit: WJZ Baltimore - Published on January 30, 2021 

You might like